Belmont Global Advisors’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$468K Sell
2016
Q2
$680K Sell
2016
Q1
$868K Buy
2015
Q4
$556K Buy